ONGOING CLINICAL TRIALS
ZymoGenetics is conducting the following clinical trials.
For more information about a study, click on one of the links below.
|
Product Candidate |
Medical area & Stage of development |
| rThrombin |
For control of surgical bleeding - Pre-Registration |
| IL-21 |
For treatment of metastatic melanoma, renal cell carcinoma and lymphoma - Phase 1/2 |
| Atacicept |
For treatment of autoimmune diseases & B-cell malignancies - Phase 2/3 |
| PEG-interferon lambda |
For treatment of hepatitis C - Phase 1 |
| |
|
Product backgrounders
offer detailed information about each product candidate.
|
Back to top
